Research centers are an important part of the graduate and undergraduate research carried out in the department, and significantly increase the interaction between students and industry.
C2B2 is a cooperative research and educational partnership with the federal National Renewable Energy Laboratory, the Colorado School of Mines, the University of Colorado at Boulder and Colorado State University.
The center provides private industry with one-stop access to researchers, laboratories, students, and educators from four innovative institutions, each having unique strengths in biofuel and biorefining application areas.
C2B2 currently has 22 industrial sponsors including: Chevron, ConocoPhillips, Ecopetrol, Genencor/Danisco, General Motors, Shell Global Solutions and Valero, in addition to small businesses, and start-up companies.
RASEI reflects a three pronged approach through discovery, transformation, and entrepreneurship in linking the University's research in renewable and sustainable energy with climate and environmental science, behavioral science, and policy analysis, to name a few.
RASEI was developed to solve the energy crisis through research, education and technology. The Institue was launched in 2006 by co-directors Carl Koval of the Chemistry and Biochemistry department at the University of Colorado at Boulder and Ray Stutts of the National Renewable Energy Laboratory (NREL).
The Mechanical Engineering and Chemical and Biological Engineering Departments currently have a National Science Foundation Center for Membrane Applied Science and Technology (MAST) that is funded by NSF, Industrial Sponsors , the Colorado Commission on Higher Education, and the University of Colorado. In addition to Chemical and Biological Engineering, faculty from Chemistry and Mechanical Engineering and faculty from other Colorado schools have projects with the Center.
The BioFrontiers Institute, formerly the Colorado Initiative in Molecular Biotechnology (CIMB), was founded at the University of Colorado to:
The BioFrontiers Institute is uniquely defined both by its excellent researchers and leadership, and by the scientific and geographical ecosystem that empowers their work.
The Institute is housed in the state-of-the-art Jennie Smoly Caruthers Biotechnology Building on CU-Boulder’s East Campus. This new facility brings together the Initiative’s scientific passion and drive with the resources it takes to explore critical areas of unknown biology and translate that knowledge into applications that will advance human health and welfare.
The Center for Pharmaceutical Biotechnology is jointly run by the Department of Chemical Engineering and the School of Pharmacy and is funded by industrial sponsors. The Center is divided into three research cores: (i) pharmaceutics, covering drug stability and drug delivery research, (ii) molecular biology, where recombinant DNA technology is employed to identify new drug targets, synthesize macromolecular therapeutics, and understand the molecular basis of disease, and (iii) analytical chemistry, where new methods are developed to characterize macromolecular structure, in vivo drug concentrations, and drug purity.
Opportunities for graduate research associated with the Center for Pharmaceutical Biotechnology include the NIH-sponsored Leadership in Pharmaceutical Biotechnology Training Program.
The Industry/University Cooperative Research Center for Fundamentals and Application of Photopolymerization is operated jointly with the University of Iowa. It is currently funded by six companies and NSF. The center strives to increase the understanding of kinetics and mechanics of photopolymerizations and their applications. In addition, the center strives to create an interface between industrial scientists and the academics.